The effects of Danggui-Shaoyao-San on neuronal degeneration and amyloidosis in mouse and its molecular mechanism for the treatment of Alzheimer's disease

被引：21
|
作者：
Yang, Cong [1 ,2 ]
Mo, You-Sheng [1 ,2 ]
Chen, Hui-Fang [1 ,2 ]
Huang, Yan-Hui [1 ,2 ]
Li, Shao-Ling [1 ,2 ]
Wang, Hong [1 ]
Huang, Shui-Qing [1 ,2 ]
Chang, Xiang [3 ]
Du, Qun [1 ]
Wang, Qi [1 ,2 ]
机构：
[1] Guangzhou Univ Chinese Med, Sci & Technol Innovat Ctr, Guangzhou 510405, Guangdong, Peoples R China
[2] Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou 510405, Guangdong, Peoples R China
[3] Xian Hosp Tradit Chinese Med, Xian 710021, Shaanxi, Peoples R China
来源：
JOURNAL OF INTEGRATIVE NEUROSCIENCE | 2021年 / 20卷 / 02期
关键词：
Danggui-Shaoyao-San; Alzheimer's disease; Cognitive deficits; Amyloidosis; Lipoprotein receptor-related protein-1; RAGE; COGNITIVE DEFICITS; BETA; CLEARANCE; SYSTEMS;
D O I：
10.31083/j.jin2002025
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The abnormal deposition of the extracellular amyloid-beta peptide is the typical pathological hallmark of Alzheimer's disease. Strategies to reduce the amyloid-beta deposition effectively alleviate the neuronal degeneration and cognitive deficits of Alzheimer's disease. Danggui-Shaoyao-San has been considered a useful therapeutic agent known for the treatment of Alzheimer's disease. However, the mechanism of Danggui-Shaoyao-San for the treatment of Alzheimer's disease remains unclear. We investigated Danggui-Shaoyao-San's effect on amyloidosis and neuronal degeneration in an APP/PS1 mouse model. We found Danggui-Shaoyao-San alleviated the cognitive deficits in APP/PS1 mice. Additionally, Danggui-Shaoyao-San ameliorated the neuronal degeneration in these mice. Danggui-Shaoyao-San reduced the amyloidosis and amyloid-beta(1-42) deposition in APP/PS1 mouse brain and down-regulated the receptor for advanced glycation end products, and up-regulated the level of low-density lipoprotein receptor-related protein-1. However, the protein expression of the beta-amyloid precursor protein, beta-Secretase and presenilin-1 (PS1) in the amyloid-beta production pathway, and the expression of neprilysin and insulin-degrading enzyme in the amyloid-beta degradation pathway were not altered. Our findings collectively suggest that Danggui-Shaoyao-San could ameliorate the amyloidosis and neuronal degeneration of Alzheimer's disease, which may be associated with its up-regulation lipoprotein receptor-related protein-1 and down-regulation of the receptor for advanced glycation end products.
引用
收藏
页码：255 / 264
页数：10
相关论文
共 50 条
  • [41] Molecular mechanism of Acanthopanax senticosus in the treatment of Alzheimer's disease based on network pharmacology and molecular docking
    Kuang, Feng
    Xiang, Tao
    MOLECULAR DIVERSITY, 2023, 27 (06) : 2849 - 2865
  • [42] Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer's disease
    Ma, Xiaoying
    Zhao, Ying
    Yang, Tao
    Gong, Na
    Chen, Xun
    Liu, Guoli
    Xiao, Jun
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [43] The Effect of Type 2 Diabetes Mellitus on the Development of Alzheimer's Disease and Its Molecular Mechanism
    Duran, Rabia
    Pancur, Sumeyra
    BahadorI, Fatemeh
    BEZMIALEM SCIENCE, 2022, 10 (01): : 114 - 122
  • [44] Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer's Disease Mouse Model
    Kiris, Irem
    Skalicka-Wozniak, Krystyna
    Basar, Merve Karayel
    Sahin, Betul
    Gurel, Busra
    Baykal, Ahmet Tarik
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (16) : 2937 - 2950
  • [45] Effects of Memantine on Neuronal Structure and Conditioned Fear in the Tg2576 Mouse Model of Alzheimer's Disease
    Dong, Hongxin
    Yuede, Carla M.
    Coughlan, Carolyn
    Lewis, Brian
    Csernansky, John G.
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (13) : 3226 - 3236
  • [46] Effects of Memantine on Neuronal Structure and Conditioned Fear in the Tg2576 Mouse Model of Alzheimer's Disease
    Hongxin Dong
    Carla M Yuede
    Carolyn Coughlan
    Brian Lewis
    John G Csernansky
    Neuropsychopharmacology, 2008, 33 : 3226 - 3236
  • [47] The 5xFAD Mouse Model of Alzheimer's Disease Displays Early Stunting of Neuronal Development in the Dentate Gyrus: a Potential Novel Treatment Window for Dementias Associated with Amyloidosis?
    Scuderi, Grace
    Radke, Amanda
    MacMurchy, Duncan
    Ikea-Mario, Torren
    Abut, Ed
    Wallace, Olivia
    Sugiyama, Aaron
    Harry, Wren
    Hagen, Benjamin
    Magnusson, Kathy
    Hagen, Tory
    FASEB JOURNAL, 2021, 35
  • [48] Natural Products as Promising Drug Candidates for the Treatment of Alzheimer's Disease: Molecular Mechanism Aspect
    Ansari, Niloufar
    Khodagholi, Fariba
    CURRENT NEUROPHARMACOLOGY, 2013, 11 (04) : 414 - 429
  • [49] A network pharmacology method explores the molecular mechanism of Coptis chinensis for the treatment of Alzheimer's disease
    Qian, Qian
    Luo, Wen Lan
    MEDICINE, 2024, 103 (05)
  • [50] Single-cell transcriptomics unveils molecular signatures of neuronal vulnerability in a mouse model of prion disease that overlap with Alzheimer's disease
    Slota, Jessy A.
    Lamoureux, Lise
    Frost, Kathy L.
    Sajesh, Babu V.
    Booth, Stephanie A.
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345